DALLAS, June 29, 2015 /PRNewswire/ --
According to a new market research report "Aptamers Market by Type (DNA, RNA, XNA), by Application (Diagnostics, Therapeutics, R&D), by Technology (SELEX, Other Technologies), by End Users (Academic Research Institutes, Biotechnology & Pharmaceutical Companies, CRO) - Global Forecast to 2020", published by MarketsandMarkets, the global Aptamers Market is expected to reach $244.93 Million by 2020 from $107.56 Million in 2015, at a CAGR of 17.89%.
Browse 74 market Tables and 67 Figures spread through 125 Pages and an in-depth TOC on "Aptamers Market"
http://www.marketsandmarkets.com/Market-Reports/aptamers-technology-market-1167.html
Early buyers will receive 10% customization on this report.
The report provides a detailed overview of the major drivers, restraints, and opportunities impacting the global Aptamers Market along with the estimates and forecasts of the revenue and market share analysis.
The global Aptamers Market is poised for rapid growth between 2015 and 2020. Factors such as strong trend of R&D investments in biotechnology and pharmaceutical industries, the patent expiration of systematic evolution of ligands by exponential enrichment technology (SELEX), technological advancements, and the low cost and high efficiency of aptamers in binding to large molecules as compared to antibodies are driving the growth of the Aptamers Market.
Inquiry before Buying: http://www.marketsandmarkets.com/Enquiry_Before_Buying.asp?id=1167
The Aptamers Market is segmented on the basis of type, application, technology, and end user. By type, the market includes DNA-based aptamers, RNA-based aptamers, and XNA-based aptamers. DNA-based aptamers will hold the largest share of the Aptamers Market in 2015, while XNA-based aptamers will grow at the highest CAGR between 2015 and 2020.
The applications included in this report are diagnostics, therapeutics development, research and development, and others. The diagnostics application segment will hold largest share of the Aptamers Market in 2015. Therapeutics development is expected to be one of the fastest-growing applications between 2015 and 2020.
The technologies included in this report are SELEX and other technologies. SELEX will hold the largest share of the Aptamers Market in 2015. The other technologies segment is expected to grow at the highest rate between 2015 and 2020.
The end users included in this report are academic and government research institutes, biotechnology and pharmaceutical companies, contract research organizations (CROs), and other end users. Of these, the academic and government research institutes will hold the largest share of the Aptamers Market in 2015. The biotechnology and pharmaceutical companies are expected to be the fastest-growing end-user segment between 2015 and 2020.
The geographic segments included in this report are the Americas, Europe, Asia, and the Rest of the World (RoW). The Americas are expected to hold the largest share of this market in 2015, while Europe is expected to grow at the fastest rate. Growth in the European Aptamers Market will primarily be driven by the increased number of aptamer manufacturers in this region.
Major players in the global Aptamers Market are AM Biotechnologies, LLC (U.S.), Aptagen, LLC (U.S.), Aptamer Sciences, Inc. (South Korea), Aptamer Solutions Ltd. (U.K.), Aptus Biotech S.L. (Spain), Base Pair Biotechnologies, Inc. (U.S.), NeoVentures Biotechnology, Inc. (Canada), SomaLogic, Inc. (U.S.), TriLink BioTechnologies, Inc. (U.S.), and Vivonics, Inc. (U.S.).
Browse Related Reports:
Oligonucleotide Synthesis Market by Product & Services (Equipment, Reagent, Primer, Probe, Custom Oligos), End-User (Research, Pharmaceutical & Biotechnology), Application (Diagnostics, PCR, QPCR, Gene Synthesis, NGS, DNA, RNAi) - Global Forecast to 2019.
http://www.marketsandmarkets.com/Market-Reports/oligonucleotide-synthesis-market-200829350.html
Molecular Biology Enzymes, Kits, & Reagents Market by Application (Cloning, Epigenetics, PCR, Restriction Digestion, Sequencing), Product (Ligase, Phosphatase, Polymerase, Protease, Restriction Endonuclease, Reverse Transcriptase) - Global Forecast to 2018.
About MarketsandMarkets:
MarketsandMarkets is world's No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.
M&M's flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.
We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.
Contact:
Mr. Rohan
North - Dominion Plaza,
17304, Preston Road,
Suite 800, Dallas, TX 75252
Tel: +1-888-600-6441
Email: [email protected]
Visit MarketsandMarkets Blog @ http://mnmblog.org/market-research/healthcare/biotechnology
Connect with us on LinkedIn @ http://www.linkedin.com/company/marketsandmarkets
SOURCE MarketsandMarkets
Share this article